X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Inflammatory Bowel Disease (IBD) Therapeutics Companies

This report lists the top Inflammatory Bowel Disease (IBD) Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Inflammatory Bowel Disease (IBD) Therapeutics industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Inflammatory Bowel Disease (IBD) Therapeutics Top Companies

  1. Bristol-Myers Squibb

  2. Abbvie

  3. Takeda Pharmaceuticals

  4. Johnson & Johnson

  5. Bausch Health

*Disclaimer: Top companies sorted in no particular order

Inflammatory Bowel Disease (IBD) Therapeutics Market Major Players

Inflammatory Bowel Disease (IBD) Therapeutics Market Concentration

Inflammatory Bowel Disease (IBD) Therapeutics  Market Concentration

Inflammatory Bowel Disease (IBD) Therapeutics Company List

                                • Bristol-Myers Squibb Company

                                • AbbVie Inc.

                                • Allergan Therapeutics LLC

                                • Bausch Health Companies Inc. (Salix Pharmaceuticals)

                                • Rare Disease Therapeutics Inc.

                                • Johnson & Johnson Services Inc.

                                • UCB Inc.


                            Specific to Inflammatory Bowel Disease (IBD) Therapeutics Market
                            Need More Details On Market Players And Competitors?
                            Download PDF

                            Inflammatory bowel disease (IBD) Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)